Table 7.

FBB-ADHS Global Scores Rated by Teachers and Parents at Baseline and During Treatment of Children with Attention-Deficit/Hyperactivity Disorder with the Three Methylphenidate Preparations in the Intent-To-Treat–Population

	Teachers				Parents
	na	Mean	SD	Median	na	Mean	SD	Median
Baseline	103	0.76	0.57	0.60	105	1.30	0.60	1.30
Medikinet retard with a higher IR component and equivalent daily dose	99	0.72	0.64	0.55	103	1.01	0.61	0.95
Medikinet retard with similar IR component and reduced daily dose	100	0.73	0.60	0.55	104	1.12	0.70	0.95
Concerta	98	0.75	0.59	0.55	101	0.98	0.62	0.90
Differencesb Medikinet retard in equivalent daily dose–Concerta	92	−0.06	0.47	−0.06	98	0.02	0.60	0.00
Differencesb Medikinet retard in reduced daily dose–Concerta	93	−0.02	0.44	0.00	98	0.10	0.59	0.08

^an is the number of children and adolescents with ADHD with complete data on the relevant variables.

^bIndividual difference ignoring period effects.